To our new followers and supporters, we wish you a Happy and Heathy New Year! Sincerely, MongooseBio* * the new biotech in Houston Texas disrupting the adoptive autologous T cell therapy field by combining the discovery of highly immunogenic native TCR targets with clinical stage epigenetic central memory T cell reprogramming
Mongoose Bio Inc.
Biotechnology Research
Houston, Texas 426 followers
Delivering clinically proven epigenetically programmed memory TCR-T cells
About us
Mongoose Bio is a clinical stage biopharmaceutical company that is discovering and developing cellular immunotherapies for solid cancers using a combination of proprietary methodologies including the Immunopeptidome Discovery Platform and Epigenetic Memory T Cell Reprogramming to develop next-generation adoptive TCR-T cell therapies.
- Website
-
www.mongoosebio.com
External link for Mongoose Bio Inc.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Houston, Texas
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
Get directions
Houston, Texas, US
Employees at Mongoose Bio Inc.
Updates
-
Hi! We're Mongoose Bio - an early-stage clinical company revolutionizing the delivery of T cell precision therapies against common and rare solid tumors. What should you know about our approach? Well, we've developed a unique and disruptive approach to adoptive T cell therapies using epigenetic reprogramming of autologous Tcm cells harboring defined TCR’s against empirically validated highly immunogenic tumor targets to generate active and persistent TCR-T therapeutics. We believe our approach has several distinct advantages: - Reprogramed central memory T cells (Tcm) offer a significant opportunity to minimize toxicity, accommodate outpatient-based treatments and innovative combination strategies; - Reprogramed Tcm are differentiated from TIL and CAR-T products that typically rely on terminally differentiated Teff and Tex cells that have reduced regenerative capacity, are rarely persistent, and only display limited efficacy. Interested? Stay tuned..... www.mongoosebio.com Info@mongoosebio.com